DOMINIC D PHARMA SERVICE LTDActive

Company number 11653207Private limited companyIncorporated 2018

Key figures

£6,341+39.3%
Net assets 2025/26
+8.4%
Average annual growth 2020/21–2025/26
02 k4 k6 k8 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, DOMINIC D PHARMA SERVICE LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Total assets5,51315,26510,99213,97714,781
Total liabilities1,72414,47810,6369,4258,440
Net assets / total equity3,7897873564,5526,341
Average number of employees11001

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DOMINIC D PHARMA SERVICE LTD

Company

DOMINIC D PHARMA SERVICE LTD is a private limited company registered with Companies House under company number 11653207. It was incorporated on 31 Oct 2018. Its status is active. The registered office is in Stevenage (SG2). Its nature of business (SIC 2007) is buying and selling of own real estate (68100), other letting and operating of own or leased real estate (68209), specialists medical practice activities (86220), other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 1 Apr 2026); the company files micro-entity accounts. Net assets were £6,341, up 39.3% on the previous year. Total assets were £14,781 and total liabilities £8,440. The company had an average of 1 employee. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 1 Jan 2027. The next confirmation statement is due by 11 Nov 2026.